Alam, N <br/><br/>
Risk model incorporating donor IL6 and IFNG genotype and gastrointestinal GVHD can discriminate patients at high risk of steroid refractory acute GVHD.  [electronic resource] 

 -  Bone marrow transplantation  May 2015 
 - 734-42 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1476-5365 
<br/><br/><label>Standard No.: </label>10.1038/bmt.2015.19  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Aged<br/>Aged, 80 and over<br/>Disease-Free Survival<br/>Female<br/>Genotype<br/>Graft vs Host Disease--genetics<br/>Humans<br/>Incidence<br/>Interferon-gamma--genetics<br/>Interleukin-6--genetics<br/>Male<br/>Middle Aged<br/>Models, Biological<br/>Polymorphism, Single Nucleotide<br/>Risk Factors<br/>Survival Rate<br/>Unrelated Donors